Sort
85,873 grants matching “alzheimers”
Personality Prediction of Dementia Risk and Progression
$2,274,616Daniel K. Mroczek · Northwestern University At Chicago · RF1 · FY2024 · AG
Air Pollution, Metabolome, and Alzheimer disease in Mexican Americans
$2,274,447Beate R Ritz · University Of California Los Angeles · RF1 · FY2022 · NS
Impact of AD/ADRD on Health-Related Outcomes in a Statewide Population Enrolled in a Publicly-Funded HCBS Waiver Program for Older Adults
$2,274,359Richard H Fortinsky · University Of Connecticut Sch Of Med/Dnt · RF1 · FY2020 · AG
Alzheimer's Disease Research Center
$2,273,968Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · AG
Probing early protein aggregation mechanisms and their relationship to disease ef
$2,272,500Songi Han · University Of California Santa Barbara · DP2 · FY2011 · OD
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$2,272,422Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · AG
Alzheimer's Disease Research Center
$2,271,968Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · AG
Mitochondrial Complex I as a Target for Neuroprotection in AD
$2,271,860Eugenia Trushina · Mayo Clinic Rochester · RF1 · FY2022 · AG
Entorhinal-hippocampal interactions during progressive memory impairments in mouse models of Alzheimer's disease pathology
$2,271,330Tristan Shuman · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · AG
Autophagy, Inflammation and Metabolism (AIM) in Disease Center - Phase 2.
$2,270,783Vojo P Deretic · University Of New Mexico Health Scis Ctr · P20 · FY2023 · GM
Mitochondria and metabolism in neurodegeneration
$2,270,540John William Elrod · Temple Univ Of The Commonwealth · RF1 · FY2021 · NS
Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials
$2,270,000Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2023 · AG
Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models
$2,269,734Inma Cobos · Stanford University · R01 · FY2025 · AG
Genetics of Alzheimer's Disease in Mexico
$2,269,393Giuseppe Tosto · Columbia University Health Sciences · R56 · FY2019 · AG
Understanding the role of senescence on post-operative neuroinflammation
$2,268,715Shyni Varghese · Duke University · RF1 · FY2022 · AG
African Ancestry and the Genomic Architecture of AD and Other Common Neurodegenerative Disease Neuropathologies
$2,268,369David A Bennett · Rush University Medical Center · R01 · FY2017 · AG
Disease Model Development and Phenotyping Project
$2,268,051Gareth R Howell · Indiana University Indianapolis · U54 · FY2016 · AG
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
$2,267,650Tamara Dubowitz · Rand Corporation · R01 · FY2022 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,267,275Mount Sinai School Of Medicine Of Nyu · P50 · FY2000 · AG
Mechanisms of X-Chromosome-dependent Sex Difference inAlzheimers Disease
$2,267,022Dena Bou Dubal · University Of California, San Francisco · RF1 · FY2020 · AG
Kansas Center for Implementation Science
$2,266,697Christie Befort · University Of Kansas Medical Center · P20 · FY2025 · GM
Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry
$2,266,674Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2023 · AG
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$2,265,244Susan Abushakra · Alzheon, Inc. · R01 · FY2024 · AG
Multimodal Characterization of the Role of Circular RNAs in Alzheimer's Disease
$2,265,243Carlos Cruchaga · Washington University · RF1 · FY2022 · AG
Urban Air Pollution and Alzheimer's Disease: Risk, Heterogeneity, and Mechanisms
$2,264,495Caleb E Finch · University Of Southern California · P01 · FY2022 · AG